News - UF Innovate

1-2-3: UF Supercomputer No. 1 in U.S. for Energy Efficiency; No. 2 in U.S., No. 3 Worldwide in Higher Ed

The University of Florida’s HiPerGator AI supercomputer has been named one of the most powerful worldwide, according to rankings just released by TOP500, the most referenced global ranking of high-performance computing systems.

Deep Brain Stimulation Settings May Be Successfully Managed at Home After Surgery, Study Shows

New research shows that people receiving deep brain stimulation, or DBS, for the treatment of Parkinson’s disease may be managed successfully at home by a home health nurse in the months following surgical implantation.

UF/IFAS Plows Forward To Breed and Grow a ‘Superfood,’ the Pomegranate

Zhanao Deng, a University of Florida environmental horticulture professor, is trying to breed and grow more pomegranates in Florida.

Putting Corporate Back into Wellness Benefits with Ed Buckley of Peerfit

Ed Buckley, CEO of UF startup Peerfit, a digital health technology company, talked with Laura Cave and Mike Zarrillo, hosts of the Better Benefits podcast, about creating better wellness benefits that employees will actually use.

Harley Collaborates With MAE & Informatics Institute To Better Understand HEAs

ECE Assistant Professor Joel Harley is embarking on a unique collaboration with Douglas E. Spearot from the Department of Mechanical & Aerospace Engineering (MAE)—using a UF Informatics Institute Seed Fund Program grant to better understand how a high entropy alloy (HEA) works on an atomic level.

The V Foundation Announces Renewed Research Support for UF’s Dr. Duane Mitchell

During the 16th annual Dick Vitale Gala, the V Foundation for Cancer Research announced that Duane Mitchell, M.D., Ph.D., director of the UF Clinical and Translational Science Institute, assistant vice president for research at UF and co-leader of the UF Health Cancer Center’s Cancer Therapeutics & Host Response research program, will receive additional support for his research on brain cancer in children.

Atsena Therapeutics Receives Orphan Drug Designation From the FDA for Novel Gene Therapy To Treat Genetic Eye Disease LCA1

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for its investigational gene therapy product for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1), a genetic eye disease that affects the retina.

UF Researchers Aim to One Day Farm on Mars

UF researchers are playing a part in the future of space agriculture. One of the co-directors of the UF Space Plants Lab said all the research they do has one main goal, to one day grow plants on Mars.

Clearlake Capital and Siris-Backed Constant Contact Agrees To Acquire SharpSpring

Constant Contact, an established leader in online marketing, backed by Clearlake Capital Group, L.P. and Siris Capital, announced it has signed a definitive agreement to acquire UF startup SharpSpring, Inc., a leading cloud-based sales and marketing automation platform, in an all-cash transaction valued at approximately $240 million including outstanding indebtedness.

Mental Confusion, Disorientation May Be Early Warning Sign of Severe COVID-19

A new University of Florida study finds that patients with COVID-19 who displayed symptoms of disorientation and confusion were three times more likely to go on to develop severe COVID-19 than patients with the virus who did not experience neurological symptoms.

UF News